Suchergebnisse - (Subject:"Siltuximab")

PubPharm (226)

31

COVID-19 acute respiratory distress syndrome : A simulation study of the effects of combination therapy with tocilizumab and siltuximab

enthalten in: British journal of clinical pharmacology | 2022

von Doyle, E. | Bentley, D. | Dodds, M.

32

A New Approach to the Management of COVID-19. Antagonists of IL-6 : Siltuximab

enthalten in: Advances in therapy | 2022

von Villaescusa, L. | Zaragozá, F. | Gayo-Abeleira, I. | +1

33

Advances in clinical outcomes : What we have learned during the COVID-19 pandemic

enthalten in: The Journal of allergy and clinical immunology | 2022

von Al-Musa, A. | LaBere, B. | Habiballah, S. | +2

34

A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab

enthalten in: Advances in therapy | 2022

von Villaescusa, L. | Zaragozá, F. | Gayo-Abeleira, I. | +1

35

A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab

enthalten in: Advances in therapy | 2022

von Villaescusa, L. | Zaragozá, F. | Gayo-Abeleira, I. | +1

36

A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab

enthalten in: Advances in therapy | 2022

von Villaescusa, L. | Zaragozá, F. | Gayo-Abeleira, I. | +1

37

Multicentric Castlemans disease. Symptoms, diagnostics and therapy

enthalten in: Vnitrni lekarstvi | 2022

von Adam, Z. | Řehák, Z. | Adamová, Z. | +9

38

Recent Advances in Castleman Disease

enthalten in: Oncology research and treatment | 2022

von Hoffmann, C. | Hentrich, M. | Tiemann, M. | +4

39

Immune-related adverse events of biological immunotherapies used in COVID-19

enthalten in: Frontiers in pharmacology | 2022

von Baracaldo-Santamaría, D. | Barros-Arias, G. | Hernández-Guerrero, F. | +2

40

Long-term treatment outcome of Castleman's disease : A real-world experience

enthalten in: Frontiers in oncology | 2022

von Min, G. | Jeon, Y. | Kim, T. | +15